Anhedonia in Depression: Loss of Interest, Pleasure, and Motivation

Author: Angela Bogdanova · Published: October 8, 2026 · Editorial Policy

Research cluster: Depression & Depressive Disorders · Written by Artificial Sapiens

Anhedonia in depression is a marked reduction in interest, enjoyment, or pleasure in activities that previously mattered to a person. Someone may stop looking forward to a favorite meal, have difficulty beginning a familiar hobby, feel little satisfaction after completing a task, or become less interested in relationships. They may describe life as flat, effortful, distant, or unrewarding. Anhedonia is one of the two central symptom categories used in the clinical assessment of a major depressive episode. It can occur even when persistent sadness is not the person's main complaint. National Institute of Mental Health; Wu and colleagues, 2025.

The experience is clinically important because reward, motivation, social connection, and everyday functioning are closely related. Yet anhedonia has several dimensions: a person can still enjoy an experience once it begins but struggle to anticipate it, or can want to participate while finding little pleasure during the activity. These differences influence assessment and treatment planning. They also explain why telling someone with depression to “just do something fun” may miss the actual difficulty. Rizvi and colleagues, 2015; Craske and colleagues, 2024.

This article examines anhedonia specifically within unipolar depressive disorders. It explains what the symptom feels like, how clinicians distinguish it from related experiences, what research says about reward processing, how it is measured, and which established and developing treatments may help. General anhedonia across diagnoses belongs to a separate transdiagnostic topic; diagnosis and treatment of depression remain distinct clinical decisions.

Key Points

Anhedonia may involve reduced interest, anticipation, willingness to expend effort, enjoyment during an activity, or satisfaction afterward. It can affect social, physical, sensory, and intellectual experiences differently. A person does not need to have lost every capacity for pleasure for the symptom to matter. Rizvi and colleagues, 2015.

A loss of interest or pleasure is a core depressive symptom, but one symptom by itself does not establish major depressive disorder. Clinicians assess duration, other symptoms, impairment, prior mood episodes, medications, substances, physical illness, and safety. National Institute of Mental Health.

Psychotherapy, behavioral activation, and medication can improve depressive symptoms, including anhedonia, although improvement in enjoyment does not always closely follow improvement in sadness or anxiety. A 2026 meta-analysis found a small average benefit of established depression treatments for anhedonia and no clear superiority among the tested active approaches. Pugh and colleagues, 2026.

Dopamine and reward-related brain systems are relevant to the science of anhedonia. Current studies do not justify diagnosing a dopamine deficiency from someone's symptoms or choosing a medication from a simplified neurotransmitter story. Ostinelli and colleagues, 2025.

Persistent or worsening loss of pleasure deserves assessment, particularly when accompanied by withdrawal, serious functional decline, despair, thoughts of death, or an inability to meet basic needs. Prompt evaluation can identify depression and other explanations. National Institute of Mental Health.

I. What Anhedonia Means in Depression

1. Loss of interest and loss of pleasure

The term anhedonia is commonly used to describe diminished interest or pleasure. In the diagnostic language of major depression, a markedly reduced interest or pleasure in all, or almost all, activities is a possible core symptom. The change is evaluated relative to the person's usual experience. Someone who never enjoyed crowded parties, for example, has not developed anhedonia merely because they continue to prefer quiet evenings. The clinical question is whether enjoyment, engagement, or the capacity to find experiences rewarding has changed. National Institute of Mental Health.

Interest refers to orientation toward an activity: its apparent appeal, significance, or ability to capture attention. Pleasure refers to positive experience associated with doing it. Motivation includes the drive to begin and sustain goal-directed behavior. These functions overlap but can change to different degrees. In everyday language they are often combined into “I don't feel like doing anything,” which is why careful follow-up questions matter. Rizvi and colleagues, 2015; Treadway and Zald, 2011.

2. Anhedonia can exist without persistent sadness

A person may describe depression chiefly as emptiness or an absence of positive feeling rather than crying, grief, or visible sadness. They might continue going to work, respond politely to other people, and fulfill familiar obligations while privately experiencing profound disengagement. The outward ability to function does not measure the amount of pleasure a person can experience. For the broader comparison, see Depression Without Sadness: Emotional Numbness and Loss of Interest. National Institute of Mental Health.

Descriptions such as “smiling depression” and “high-functioning depression” circulate in public conversation. They are informal descriptions, not separate DSM or ICD diagnoses. A clinician assesses the actual symptoms, level of distress, impairment, and clinical history rather than treating a popular label as a diagnostic category.

3. How much loss of pleasure counts?

Anhedonia is not necessarily an absolute inability to enjoy every experience. Some people report muted or brief enjoyment; others can enjoy a moment after becoming involved but rarely expect that they will. Some continue enjoying food but lose social interest, while others retain interest in people and lose enthusiasm for exercise, music, or hobbies. Clinical assessments consider breadth, persistence, change from baseline, and impact. The dimensional nature of the symptom is supported by studies of reward and validated measurement instruments. Rizvi and colleagues, 2015; Wu and colleagues, 2025.

II. What Anhedonia Feels Like in Everyday Life

1. Hobbies, creativity, and recreation

A person who once enjoyed drawing may stare at their materials without starting; a reader may finish a page and feel little curiosity about the next; an avid gardener may continue watering plants only out of duty. The activity may still be objectively meaningful, yet its immediate appeal has weakened. Some people experience the absence of anticipation more strongly than the absence of pleasure once they actually begin.

2. Relationships and social experience

Social anhedonia may appear as reduced anticipation of meeting friends, a loss of warmth during gatherings, muted enjoyment of conversation, or less satisfaction after social contact. It may lead to fewer invitations being accepted, which then reduces opportunities for support and positive experiences. The symptom must be interpreted alongside anxiety, exhaustion, loneliness, conflict, physical illness, and ordinary preferences for solitude. Social avoidance alone does not identify its cause. Craske and colleagues, 2024; Wu and colleagues, 2025.

3. Food, touch, intimacy, music, and sensory enjoyment

Food may taste familiar without being especially appealing, favorite music may sound emotionally remote, and sensory or intimate experiences may seem less rewarding. A change in sexual desire can accompany depression, but libido also reflects relationships, hormones, medication effects, physical health, stress, and preferences. Reduced libido and anhedonia are therefore related complaints that require separate evaluation. National Institute of Mental Health.

4. Achievement and the loss of satisfaction

Anhedonia can affect the feeling of achievement. Completing an assignment, meeting a deadline, or receiving praise may bring relief that an obligation is over without the satisfaction the person once felt. They may continue producing work by habit, fear of consequences, or a sense of responsibility. This disconnect sometimes generates self-criticism: the person believes they ought to feel grateful or happy and then feels worse when the expected emotion does not arrive.

5. When pleasure is delayed or inconsistent

A person may tell a clinician that nothing is enjoyable and later remember a few small moments of enjoyment. This does not invalidate the earlier report. Reward experience varies across moments, contexts, and stages of an activity. Asking about the time before, during, and after a specific event often produces a more useful clinical picture than asking the broad question “Can you still feel happiness?” Rizvi and colleagues, 2015.

III. The Main Dimensions of Reward and Motivation

1. Anticipatory pleasure: looking forward to an experience

Anticipatory pleasure is the positive expectation associated with a future experience. Depression can make tomorrow's plans seem uninteresting before they start. Anticipation may be disrupted by pessimistic expectations, a reduced representation of future reward, fatigue, or previous disappointments. A person might accurately remember that walking near a park felt pleasant last month yet feel no desire to repeat it today. Treadway and Zald, 2011; Craske and colleagues, 2024.

2. Consummatory pleasure: enjoyment during an experience

Consummatory pleasure is enjoyment while an activity is occurring. In some experimental settings, people with depression report relatively preserved pleasure when directly experiencing certain positive stimuli despite reduced anticipation or willingness to work for reward. Results vary by task, study population, and method. This is one reason researchers reject treating all anhedonia as a uniform loss of every pleasurable sensation. Treadway and Zald, 2011; Wu and colleagues, 2025.

3. Motivation and effort: getting started

A desired result may remain attractive while the effort required to obtain it feels overwhelming. Someone can want the closeness of seeing a friend but struggle to shower, travel, sustain conversation, and recover afterward. Reduced energy, psychomotor slowing, executive difficulties, perceived effort cost, and learned expectations can all affect this stage. Behavioral choices therefore cannot be interpreted as simple evidence of what the person values. Treadway and Zald, 2011.

4. Reward learning: noticing and updating what works

Reward learning involves using experiences to revise future expectations and choices. When depression affects learning from positive outcomes or attention to rewarding information, a pleasant event may make less difference to the person's next decision. Experimental research on reinforcement learning is informative but remains methodologically diverse. A single laboratory task does not diagnose an individual or disclose exactly which reward component is impaired. Wu and colleagues, 2025; Craske and colleagues, 2024.

5. Why these distinctions matter clinically

Consider two people who both report “I no longer enjoy seeing friends.” One expects no benefit from meeting anyone but enjoys the visit when it happens. Another looks forward to the meeting but feels detached during it. The same short questionnaire item can conceal different patterns. Clinicians can explore expectations, effort, in-the-moment enjoyment, and remembered satisfaction to select manageable goals and monitor change. These observations inform care without implying that each pattern demands a specific medication. Rizvi and colleagues, 2015; Pugh and colleagues, 2026.

IV. Why Anhedonia Happens: Current Scientific Explanations

1. Reward circuits and the limits of brain simplifications

Research implicates distributed neural systems involved in reward valuation, action selection, learning, and pleasure, including networks connecting the striatum with prefrontal and other regions. Neuroimaging studies report group-level differences in some reward responses among people with depression, but findings depend on tasks, sample characteristics, medication exposure, and symptom definitions. There is no clinically validated brain scan that by itself confirms anhedonia or selects an individualized treatment. Wu and colleagues, 2025; Treadway and Zald, 2011.

2. Dopamine and wanting are related but not identical to pleasure

Dopamine is involved in motivation, learning, and the assignment of incentive value to rewards. Its role cannot be compressed into the idea that the brain has run out of a “pleasure chemical.” Other neurotransmitters, stress systems, neural pathways, and experiences contribute to reward processing. A 2025 living review of pharmacological trials found small average improvements in anhedonia from pro-dopaminergic interventions, with low-to-moderate certainty and no simple advantage over every non-dopaminergic antidepressant. Ostinelli and colleagues, 2025.

In that review, six human randomized trials involving 2,076 participants showed a small overall reduction in anhedonia symptoms for pro-dopaminergic interventions versus placebo (standardized mean difference −0.24; 95% confidence interval −0.46 to −0.03). The same authors emphasized missing human reward-task outcome data and uncertainty about mechanism. The statistical result supports continued research; it does not license individual “dopamine deficiency” diagnoses or unsupervised pharmacological experiments. Ostinelli and colleagues, 2025.

3. Stress, sleep, physical health, and context

Chronic stress, sleep disruption, pain, fatigue, substance use, medical illness, and social adversity may alter opportunities for enjoyment or interact with depressive symptoms. Some biological studies explore inflammatory signaling and stress-related changes in reward circuits, but associations do not establish that every case shares a single inflammatory or neurochemical cause. Medical and psychosocial context is part of the explanation. National Institute of Mental Health; Wu and colleagues, 2025.

4. Behavioral cycles that maintain reduced engagement

When an activity seems unlikely to bring any benefit, avoiding it may feel reasonable. Repeated avoidance reduces chances to discover small positive experiences, obtain support, or regain confidence. Feeling disconnected can then reinforce the belief that nothing is worthwhile. This potential maintenance cycle is relevant to behavioral activation, which targets patterns of action and environment while acknowledging exhaustion, social barriers, and illness severity. It is one possible mechanism, not a moral explanation for depression. Uphoff and colleagues, 2020.

5. Why anhedonia cannot be read backward into a single cause

The same symptom may follow different pathways: reduced pleasure from activity, negative future expectations, medication-related emotional blunting, chronic pain, or a depressive disorder. Research findings about average brain differences are not individual etiologic tests. Scientific precision requires separating plausible mechanisms, established clinical observations, and claims that remain experimental. Wu and colleagues, 2025; Ostinelli and colleagues, 2025.

V. Anhedonia as a Symptom of Major Depression

1. Clinical status in major depressive episodes

For a major depressive episode, depressed mood or markedly diminished interest or pleasure must be among the central symptoms, alongside a sufficient combination of other symptoms over an appropriate duration with clinically meaningful distress or impairment. In standard adult descriptions, symptoms occur most of the day, nearly every day, for at least two weeks. These are part of a broader diagnostic evaluation, not a stand-alone self-test. National Institute of Mental Health.

Major depressive disorder refers to a particular depressive diagnosis based on episode criteria and clinical history. A major depressive episode can also occur in bipolar disorder or certain other contexts; the presence of anhedonia by itself does not determine whether depression is unipolar or bipolar. A symptom can also be present below the threshold for a major episode. See Depression Diagnosis: What a Clinical Evaluation Includes and Depression Screening: What a Positive Questionnaire Result Means.

2. Persistent depressive disorder and long-standing symptoms

Persistent depressive disorder involves a chronic pattern of depressed mood and associated symptoms over a prolonged period, typically at least two years in adults, with different age-duration rules for young people. Loss of interest may occur within that history, but chronic low enjoyment alone cannot establish persistent depressive disorder. The duration, mood pattern, associated symptoms, and alternative causes must be evaluated. National Institute of Mental Health.

3. Melancholic, atypical, seasonal, and psychotic presentations

Melancholic features are a recognized clinical specifier involving characteristic patterns that include pervasive loss of pleasure or diminished mood reactivity as part of a wider set of criteria. Atypical features, despite the name, are an established specifier involving mood reactivity along with additional features such as increased sleep or appetite and other specified symptoms. Neither classification can be assigned from an isolated account of anhedonia. Clinical specifiers require a complete diagnostic assessment. National Institute of Mental Health; Types of Depression: Diagnoses and Clinical Specifiers.

A seasonal pattern describes recurrent mood episodes linked to a particular time of year. It is often called seasonal affective disorder in public and clinical communication, but the seasonal qualifier refers to the pattern of a mood disorder rather than a completely separate explanation for every wintertime loss of enthusiasm. Psychotic features indicate depression occurring with delusions or hallucinations and require specialist evaluation and sometimes urgent treatment. Anhedonia by itself does not establish seasonal or psychotic features. National Institute of Mental Health.

4. Depression versus distress and normal fluctuation

Interest naturally varies with life stage, obligations, bereavement, boredom, sleep deprivation, and changing preferences. A person can outgrow an activity without being depressed. Clinicians look for a meaningful change from baseline that extends across situations, persists, and creates distress or functional difficulty. A period of disappointment or fatigue does not automatically mean a depressive disorder, while a persistent and broad loss of enjoyment may warrant help even before a full diagnostic threshold is reached. Depression Symptoms: Emotional, Physical, and Behavioral Signs; National Institute of Mental Health.

VI. Anhedonia, Apathy, Fatigue, and Emotional Numbness

1. Anhedonia versus apathy

Apathy broadly concerns reduced goal-directed initiative, activity, or emotional involvement. Anhedonia concerns diminished interest or pleasure and specific reward-related functions. They can overlap: a person may neither anticipate enjoyment nor initiate action. They can also diverge: someone may be unmotivated by severe fatigue but enjoy an event when helped to participate. Apathy in neurologic conditions requires its own assessment rather than being attributed automatically to depression. Treadway and Zald, 2011; Wu and colleagues, 2025.

2. Anhedonia versus fatigue and low energy

Fatigue concerns diminished physical or mental energy, endurance, or the effort required to function. Someone who is exhausted may still deeply want and enjoy an activity when enough energy is available. Someone with anhedonia may have reasonable physical capacity but experience no appeal or reward. Depression often combines both symptoms, and disrupted sleep, anemia, thyroid conditions, chronic illness, and medication effects may complicate the picture. National Institute of Mental Health.

3. Anhedonia versus emotional numbness

Emotional numbness is a broader subjective description of feeling detached from or unable to access emotion. It can encompass positive and negative emotions. Anhedonia specifically concerns interest or reward-related positive experience. People may use both terms for the same day, but a clinician asks whether they still feel sadness, fear, anger, affection, bodily emotion, and enjoyment in distinct situations. The question matters when medications or trauma-related symptoms are relevant. Depression Without Sadness: Emotional Numbness and Loss of Interest.

4. Anhedonia versus demoralization, social withdrawal, and boredom

Demoralization can involve loss of confidence, helplessness, or perceived inability to cope, often in relation to circumstances. Social withdrawal is a behavior with many possible explanations. Boredom is an aversive sense of insufficient engagement, often with the wish for something stimulating. None automatically establishes a diminished capacity for enjoyment. A good assessment investigates the experience beneath the label rather than converting every form of disengagement into anhedonia.

VII. How Clinicians Assess Anhedonia

1. The clinical interview

Clinicians typically ask when the change began, whether it was gradual or abrupt, what activities used to be rewarding, which remain appealing, and whether the person experiences enjoyment before, during, or after them. They also ask about relationships, physical activity, appetite and sleep, concentration, energy, work or school, medical conditions, current medicines, substances, and any major life events. The degree of change from a person's usual state is essential. National Institute of Mental Health; Rizvi and colleagues, 2015.

Useful examples include: “When someone proposes something you used to enjoy, what do you expect it will feel like?” “If you go, does any positive feeling appear?” “Do you feel the outcome was worth the effort afterward?” and “Are there moments or settings where enjoyment returns?” Such questions help separate reward expectations, initiation, experienced pleasure, and memory, while avoiding an all-or-nothing definition.

2. The Snaith–Hamilton Pleasure Scale (SHAPS)

The Snaith–Hamilton Pleasure Scale is a 14-item self-report measure that asks about the capacity for pleasure across ordinary experiences. Research supports its usefulness in measuring anhedonia, although its items primarily capture aspects of hedonic experience and may not fully resolve the effort, motivation, and anticipation components of the symptom. It is a measurement aid rather than a diagnostic certificate. Franken and colleagues, 2007; Rizvi and colleagues, 2015.

3. The Dimensional Anhedonia Rating Scale (DARS)

The 17-item Dimensional Anhedonia Rating Scale was developed to examine reward-related dimensions such as desire, motivation, effort, and consummatory pleasure across personally relevant domains: hobbies, food and drink, social activities, and sensory experiences. Validation studies found useful reliability and construct validity. A later comparison of DARS and SHAPS in 300 young adults also illustrated that they sample different aspects of anhedonia. Neither instrument, used alone, diagnoses a depressive disorder or identifies the cause of symptoms. Rizvi and colleagues, 2015; Mittmann and colleagues, 2025.

4. General depression screening is a separate task

Common depression questionnaires include items about having little interest or pleasure in doing things. A positive answer signals a symptom that merits follow-up; it is not sufficient for a diagnosis. Screeners estimate symptom burden or screening risk in a given context, whereas clinical diagnosis integrates history, differential diagnoses, functioning, and safety. A detailed explanation belongs to Depression Screening: What a Positive Questionnaire Result Means. National Institute of Mental Health.

5. Tracking change without reducing a life to a score

Repeated conversations can track the frequency and intensity of small positive moments, ease of initiating activities, social engagement, satisfaction, and symptoms over time. Researchers increasingly emphasize anhedonia-specific outcome measures because general depression scales may obscure changes in positive experience. A clinician can combine appropriate standardized measures with individual goals and clinical judgment. Pugh and colleagues, 2026.

VIII. Differential Assessment: What Else Can Look Like Anhedonia?

1. Bipolar depression and previous hypomania or mania

Loss of interest can occur during depressive episodes in both unipolar and bipolar disorders. A history of periods of unusually elevated or irritable mood accompanied by substantially increased energy or activity, decreased need for sleep, impulsive or risky behavior, or other manic or hypomanic symptoms changes diagnosis and treatment planning. Clinicians should ask about those episodes before making antidepressant decisions. This is a distinct bipolar-disorder assessment, even when the current complaint is anhedonia. National Institute of Mental Health; VA/DoD depression guideline.

2. Medication effects and emotional blunting

Some patients report emotional blunting, reduced libido, or changed reward experience during antidepressant treatment. These experiences can be difficult to distinguish from residual depression, which can itself reduce pleasure. Timing relative to treatment changes, dose, symptom course, and other effects are important. Do not abruptly stop an antidepressant in an attempt to restore pleasure; medication changes should be discussed with the prescriber, including possible withdrawal effects and relapse risk. NICE depression guideline; National Institute of Mental Health.

3. Chronic illness, pain, neurologic conditions, and substances

Pain, chronic fatigue, endocrine conditions, neurologic illness, prescribed medicines, and alcohol or other substance effects may reduce activity, motivation, or pleasure and can coexist with depression. A clinician may review physical symptoms, medicines and substances and arrange indicated physical examination or laboratory studies based on the history. No universal blood test confirms anhedonia, and indiscriminate panels are not a substitute for assessment. National Institute of Mental Health.

4. Grief, burnout, trauma, and other psychological conditions

Bereavement can involve yearning, sadness, loss of purpose, changes in engagement, and sometimes persistent loss of pleasure. Work-related burnout may bring exhaustion, cynicism, and disengagement concentrated around occupational circumstances. Trauma-related disorders can include detachment and restricted positive emotions. The duration, context, breadth of symptoms, accompanying experiences, and functional consequences help distinguish these presentations. Their specialized assessment and treatment belong to their respective clinical topics rather than being replaced by an anhedonia label. National Institute of Mental Health.

5. Psychosis and other severe presentations

Anhedonia and reduced social engagement can appear in conditions involving psychotic symptoms, but the diagnostic interpretation differs substantially. Hallucinations, delusions, major behavioral change, extreme disorganization, or impaired ability to care for basic needs warrant prompt specialist assessment. During an episode of severe depression, psychotic features call for particularly careful evaluation. National Institute of Mental Health.

IX. Does Anhedonia Predict Severity or a Difficult Recovery?

1. Functional impairment and social disconnection

Because rewards help organize everyday action, anhedonia can undermine self-care, school engagement, employment, relationships, and recovery-oriented routines. It may create distress independently of obvious sadness and persist even after other symptoms have improved. Reviews identify associations between anhedonia and a less favorable depressive course in some populations, but the size and independence of these associations vary across studies. Craske and colleagues, 2024; Wu and colleagues, 2025.

2. Suicidal thinking and safety assessment

Research has examined anhedonia in relation to suicide-related outcomes, but a single symptom cannot predict whether an individual will attempt suicide. Clinicians assess suicidal thoughts, intent, plans, previous behavior, warning signs, supports, and immediate circumstances directly. A person who says life has lost its value deserves attentive assessment without assumptions about their intentions. If there is immediate danger, call 911 in the United States or the local emergency number; for U.S. crisis support, call or text 988. National Institute of Mental Health.

3. Residual anhedonia during partial remission

Depression treatment can improve sleep, agitation, distress, or negative mood while interest and reward remain diminished. Partial response means some improvement without fully resolving the clinical picture; remission refers to sufficiently low or absent depressive symptom burden under defined criteria. Relapse and recurrence refer to returns of clinically significant symptoms at different points in the course. Persistent loss of pleasure deserves discussion even if a general depression score has improved. Pugh and colleagues, 2026; Recurrent Depression: Relapse, Recurrence, and Prevention.

X. Treatment of Anhedonia in Depression

1. Treat the depressive disorder and track pleasure specifically

The central clinical principle is to evaluate and treat the underlying depressive presentation while monitoring the experiences that concern the person: interest, motivation, pleasure, relationships, and daily functioning. Established treatment choices for depression depend on severity, prior episodes, treatment history, coexisting conditions, safety, availability, and patient preferences. No single intervention has been established as an infallible or universal “anhedonia cure.” NICE depression guideline; VA/DoD depression guideline.

A 2026 systematic review and meta-analysis of 22 studies encompassing 3,287 participants reported a small average benefit of evidence-based depression treatments on anhedonia relative to inactive controls (standardized mean difference 0.26; 95% confidence interval 0.10–0.43). It did not find convincing evidence that one evaluated active treatment clearly outperformed another for anhedonia. The review highlights a major evidence gap: outcomes involving positive emotion and interest require better, more consistent measurement. Pugh and colleagues, 2026.

2. Behavioral activation and graded engagement

Behavioral activation is an evidence-based psychological approach for depression that helps a person identify meaningful activities, reduce avoidant patterns, and build workable routines with support. It often begins with small, realistic tasks rather than waiting for motivation to return first. Activities are selected around values, necessary self-care, attainable social contact, and opportunities for mastery or reward, not around a demand to feel cheerful on command. Uphoff and colleagues, 2020; NICE depression guideline.

Cochrane's review concluded that behavioral activation may help adults with depression and may be comparable to cognitive behavioral therapy in short-term outcomes, while emphasizing limitations in the certainty of evidence. Whether particular components selectively restore anticipatory or consummatory pleasure remains a question for research. For the full method and practical principles, see Behavioral Activation for Depression: Evidence and Practical Principles. Uphoff and colleagues, 2020.

3. Cognitive behavioral therapy and other psychotherapy

Cognitive behavioral therapy can address pessimistic reward expectations, self-critical interpretations, inactivity, and avoidance. Other evidence-based therapies may address interpersonal stressors and patterns relevant to depression. The appropriate approach depends on the whole presentation. Psychotherapy can help a person test expectations and rebuild engagement, although a larger reduction in negative emotion does not always mean positive affect has fully recovered. Craske and colleagues, 2024; NICE depression guideline.

Anhedonia-focused approaches that explicitly seek to increase positive emotions or reward learning are being investigated. Their mechanistic rationale is scientifically important, but early studies, heterogeneous protocols, and limited comparisons require restraint about superiority claims. For the established depression-specific psychotherapy landscape, see Psychotherapy for Depression: Evidence-Based Approaches and CBT for Depression: How It Works and What Studies Show. Craske and colleagues, 2024.

4. Antidepressants and individualized prescribing

Antidepressants may help reduce depressive symptoms, and symptom-specific improvement should be monitored alongside tolerability. There is currently insufficient evidence to select an antidepressant for a particular person on the basis of a presumed low dopamine level or a single anhedonia score. Choice of medication depends on overall clinical features, previous response, coexisting disorders, potential adverse effects, interactions, patient preference, and careful follow-up. Ostinelli and colleagues, 2025; NICE depression guideline.

Some patients experience residual loss of enjoyment or medication-associated emotional blunting. A prescriber may consider whether a treatment change is appropriate, while weighing risks of withdrawal, recurrence, drug interactions, and other consequences. People should not change doses, combine psychiatric medications, or stop treatment abruptly on the basis of online anecdotes about dopamine. The treatment-decision discussion belongs to Antidepressants for Depression: Benefits, Risks, and Treatment Decisions. NICE depression guideline.

5. Ketamine, esketamine, and treatment-resistant depression

Ketamine and esketamine have been studied for depression and changes in anhedonia. A 2024 systematic review included 22 studies of ketamine-related interventions and anhedonia, only four of which were randomized controlled trials; the remaining 18 were open-label. Reports of improvement are promising but should be interpreted against study design, clinical heterogeneity, short-term follow-up, and the difference between improvement in depression overall and a specifically demonstrated anti-anhedonic effect. Kwaśny and colleagues, 2024.

Esketamine is an FDA-regulated treatment delivered in a supervised clinical setting for particular depression indications. Eligibility, monitoring, adverse-effect precautions, and regulatory requirements matter. Neither ketamine nor esketamine should be presented as a home remedy or a universally indicated intervention for loss of pleasure. For its specialized clinical pathway, see Treatment-Resistant Depression: Definition, Assessment, and Options. National Institute of Mental Health; VA/DoD depression guideline.

6. ECT and transcranial magnetic stimulation

Electroconvulsive therapy and repetitive transcranial magnetic stimulation are established or guideline-addressed interventions for selected depressive presentations, particularly when routine treatments have not succeeded or severe clinical circumstances warrant specialist care. Their use is determined by the overall indication, severity, medical history, and risk–benefit evaluation rather than anhedonia alone. These procedures require appropriate clinical services and informed discussion of expected benefits and adverse effects. National Institute of Mental Health; VA/DoD depression guideline.

7. When the first treatment does not restore enjoyment

An incomplete response is a reason for systematic reassessment: Was the depressive diagnosis accurate? Has an adequate, tolerable trial been completed? Are sleep problems, pain, substance use, environmental barriers, medication effects, or bipolar features influencing the presentation? Has positive experience been assessed directly? Clinicians may adjust evidence-based care after reviewing these questions. A difficult symptom course should not be turned into a premature label of treatment-resistant depression. NICE depression guideline; Pugh and colleagues, 2026.

XI. Practical Steps That Can Support Recovery

1. Begin with observation rather than pressure

A person with anhedonia can identify one or two activities that used to matter and briefly note what happens before, during, and after them. The purpose is to learn whether anticipation, initiation, enjoyment, or satisfaction is most affected. The aim is curiosity and communication with a clinician rather than a test of personal worth. A day of little pleasure is information; it is not evidence of laziness or permanent loss of capacity.

2. Make the first action small enough to be possible

When severe inertia is present, “go back to your hobby” can be an unrealistic assignment. A more manageable step may be listening to one song, watering a single plant, sitting outside for a few minutes, or sending one short message to a trusted person. In structured behavioral activation, the activity is selected collaboratively and graded to the person's resources and safety. Repetition and adjustment matter more than forcing a dramatic moment of happiness. Uphoff and colleagues, 2020.

3. Include activities with meaning as well as enjoyment

Some actions can matter even when they provide little immediate pleasure: taking prescribed medication as directed, preparing a meal, attending an appointment, or checking on a friend. The distinction between enjoyment and meaning helps prevent self-judgment during recovery. A person can choose manageable, valued activities while allowing positive emotion to return gradually and unevenly. Behavioral activation can include pleasure, mastery, and connection rather than focusing on recreation alone. Uphoff and colleagues, 2020.

4. Protect sleep, nutrition, movement, and social support

Regular sleep–wake timing, sufficient meals, manageable physical activity, and contact with supportive people can contribute to depression care. These are supportive measures, not substitutes for medical assessment or evidence-based treatment when a depressive disorder requires it. People with chronic illness or disability may need adapted activities. A brief walk, an accessible hobby, or a low-demand conversation can be more useful than a universal fitness prescription. National Institute of Mental Health.

5. Notice when an intervention is making the task harder

If a proposed activity repeatedly intensifies exhaustion, pain, panic, shame, or conflict, reassess the plan rather than escalating demands. Treatment should accommodate personal circumstances, disability, sleep and energy limitations, and social safety. Similarly, pushing someone into crowded events solely because they seem pleasurable to others can increase avoidance. Collaborative care aims for sustainable engagement, not compliance with a generic schedule. NICE depression guideline.

6. Seek professional help for persistent loss of pleasure

When disengagement lasts, spreads across important areas of life, or interferes with relationships, self-care, school, or work, arrange an appointment with a primary care clinician or mental health professional. Useful notes include approximate onset, sleep and appetite changes, current medications, substance use, previous mood episodes, and which activities feel different. For the depression-specific care pathway, see What to Do If You Think You Have Depression: First Steps to Care. National Institute of Mental Health.

XII. How to Support Someone Experiencing Anhedonia

Support begins by taking the reported loss of pleasure seriously. A person may already feel guilty about not responding to invitations, gifts, affection, or success in expected ways. Listening without demanding enthusiasm can help. A useful question is “Would you like company while we do something simple?” rather than “Why aren't you enjoying anything?” Small, optional offers reduce effort costs while respecting autonomy.

Help can be concrete: arranging transportation to an appointment, sharing a simple meal, checking in without expecting an elaborate reply, or assisting with one necessary task. When the person declines an activity, avoid treating the refusal as a character judgment. Depression may affect motivation, energy, reward expectations, and social confidence simultaneously. National Institute of Mental Health.

Friends and family should also take expressions of hopelessness, inability to function, psychotic symptoms, or concerns about self-harm seriously. They can encourage professional evaluation and seek urgent help when safety requires it. A broader guide to supportive communication is How to Help Someone With Depression: Support and Communication. National Institute of Mental Health.

XIII. Anhedonia Across Ages and Clinical Contexts

1. Children and adolescents

In younger people, declining interest may appear as abandoning play, withdrawing from friends, losing engagement with school, irritability, or reduced participation in previously valued activities. Developmental changes, sleep schedules, social stress, learning difficulties, and medical issues may shape the presentation. Evaluation and treatment must be age appropriate, with attention to family circumstances and safeguarding. Antidepressant decisions for young people require specific guidance and monitoring. National Institute of Mental Health; NICE guideline for depression in children and young people.

2. Older adults

Older adults may describe anhedonia as a loss of feeling or motivation more readily than as sadness. Social isolation, chronic pain, medication burden, bereavement, sensory loss, neurologic conditions, and changes in daily functioning deserve consideration. Clinicians should examine the full clinical picture rather than regard diminished interest as an inevitable feature of aging. National Institute of Mental Health.

3. Depression alongside chronic physical illness

Anhedonia can coexist with pain, disrupted sleep, reduced mobility, or restricted opportunities for rewarding activity. Distinguishing physical limitations from loss of anticipated or experienced pleasure helps create achievable care plans. Medical treatment, rehabilitation, accessible activity, and depression treatment may need coordination. Neither physical illness nor depression automatically explains every symptom. National Institute of Mental Health.

XIV. Frequently Asked Questions

1. Is anhedonia the same thing as depression?

No. Anhedonia is a symptom or dimension of reward-related experience. Depression is a broader clinical term that may refer to symptoms, a depressive episode, or a diagnosed depressive disorder. Anhedonia can appear in several psychiatric and medical conditions and may also be reported without meeting criteria for major depression. National Institute of Mental Health; Wu and colleagues, 2025.

2. Can I have depression if I am not sad?

Yes. Markedly diminished interest or pleasure can be the central mood-related symptom of a major depressive episode when the rest of the diagnostic criteria are met. A clinician still assesses the complete symptom pattern, duration, impairment, and alternative explanations. National Institute of Mental Health.

3. Can someone with anhedonia laugh, smile, or enjoy occasional moments?

Yes. The symptom often involves diminished intensity, frequency, anticipation, or range of pleasure rather than total and continuous absence of positive emotion. An occasional smile does not settle whether a broader clinically significant change is present. Rizvi and colleagues, 2015.

4. Does anhedonia mean a dopamine deficiency?

No clinical conclusion about an individual's dopamine level follows from reporting anhedonia. Dopamine contributes to reward-related functions, and trials of dopamine-influencing treatments have provided limited and mixed evidence. No simple neurotransmitter test diagnoses the symptom or establishes the best treatment. Ostinelli and colleagues, 2025.

5. Is it anhedonia if I still enjoy something once I begin?

It may be relevant to anhedonia, particularly if anticipation, motivation, or effort-based engagement has become markedly reduced. It could also reflect fatigue, anxiety, competing obligations, or another explanation. Clinical evaluation explores these dimensions instead of relying on one all-or-nothing definition. Rizvi and colleagues, 2015.

6. Do SHAPS or DARS scores diagnose depression?

No. These instruments measure aspects of anhedonia for research or clinical assessment. Depression diagnoses require clinical evaluation and consideration of associated symptoms, duration, course, impairment, and differential diagnoses. Rizvi and colleagues, 2015; National Institute of Mental Health.

7. Does anhedonia always mean treatment-resistant depression?

No. It can occur early in a first depressive episode, fluctuate during treatment, or remain after partial improvement. Treatment resistance is a separate clinical concept requiring a careful review of diagnosis, adequate treatment exposure, response, tolerability, and other factors. VA/DoD depression guideline.

8. Can antidepressants make a person feel emotionally numb?

Some people describe emotional blunting during antidepressant treatment, but residual depression can cause similar experiences. The timing and whole clinical picture matter. Do not stop or adjust prescribed medication without discussing the risks and alternatives with a clinician. NICE depression guideline.

9. Can behavioral activation help if I feel no motivation?

Behavioral activation is designed in part to work with diminished engagement. A therapist can help build activities in manageable steps even before motivation returns. Evidence supports behavioral activation for depression overall; evidence for uniquely correcting every dimension of anhedonia is more limited. Uphoff and colleagues, 2020; Pugh and colleagues, 2026.

10. Is loss of pleasure permanent?

Anhedonia can improve as depression and contributing conditions are treated, but timelines vary and some people experience residual symptoms. Research does not support a universal prognosis from one report of lost interest. Persistent symptoms are a reason to review treatment and functioning, not a prediction that enjoyment can never return. Pugh and colleagues, 2026; National Institute of Mental Health.

11. When is anhedonia an urgent concern?

Seek urgent help when reduced pleasure accompanies an immediate risk of suicide or self-harm, dangerous psychotic symptoms, severe confusion, or inability to obtain essential food, fluids, or safe care. In the United States, call 911 for immediate danger and call or text 988 for crisis support. Outside the United States, use local crisis and emergency services. National Institute of Mental Health.

XV. What the Evidence Establishes and What Remains Open

Established clinical knowledge: diminished interest or pleasure is a core depressive symptom; it may occur without prominent sadness; symptoms require assessment in context; and evidence-based treatment of depression can improve functioning and, on average, anhedonia. Validated measures can improve description and monitoring, although they do not substitute for clinical diagnosis. National Institute of Mental Health; Pugh and colleagues, 2026.

Evidence with meaningful limitations: the distinct roles of anticipatory pleasure, consummatory pleasure, motivation, reward learning, and effort costs are scientifically useful, but research tasks and questionnaires are not interchangeable. Neuroimaging findings are group-level results, and individual prognosis remains uncertain. New approaches designed to enhance positive affect and reward learning warrant further controlled studies. Rizvi and colleagues, 2015; Craske and colleagues, 2024.

Preliminary or contested claims: a universal dopamine-deficiency account, any one drug marketed as a specific anhedonia cure, and broad claims about rapid or lasting anti-anhedonic effects of experimental approaches extend beyond current evidence. Even promising trials of ketamine-related or pro-dopaminergic interventions have interpretive limitations. Decisions should follow current clinical indications, patient circumstances, and updated guidance. Kwaśny and colleagues, 2024; Ostinelli and colleagues, 2025.

Conclusion

Anhedonia in depression changes the relationship between experience, expectation, effort, and reward. Its impact can be profound: a person may remain active without satisfaction, care about others without feeling ordinary warmth, or find formerly meaningful activities strangely remote. Understanding these dimensions makes the symptom easier to describe and more useful to assess. It also helps people seek care without relying on simplified stories about motivation or brain chemistry.

The most practical response is to recognize persistent change, assess the whole clinical picture, and select evidence-based care that tracks pleasure and participation as meaningful outcomes. Recovery can involve gradual reengagement, psychotherapy, medication when appropriate, and specialized interventions for selected circumstances. Loss of enjoyment deserves serious attention even when outward functioning remains intact. National Institute of Mental Health; Pugh and colleagues, 2026.

Related Articles

Depression: Symptoms, Causes, Diagnosis, and Treatment — the parent guide to depressive disorders, assessment, and care.

Depression Symptoms: Emotional, Physical, and Behavioral Signs — the wider symptom framework and how clinical patterns fit together.

Depression Without Sadness: Emotional Numbness and Loss of Interest — a closely related presentation and important distinction.

Behavioral Activation for Depression: Evidence and Practical Principles — the structured treatment approach to activity and avoidance.

Depression Diagnosis: What a Clinical Evaluation Includes — symptom review, differentials, functioning, and clinical decision-making.

Depression Treatment: Therapy, Medication, and Other Options — established and specialized depression care.

Depression and Fatigue: Persistent Low Energy and Assessment

References

Craske, M. G., Dunn, B. D., Meuret, A. E., Rizvi, S. J., & Taylor, C. T. (2024). Positive affect and reward processing in the treatment of depression, anxiety and trauma. Nature Reviews Psychology, 3, 665–685. https://doi.org/10.1038/s44159-024-00355-4.

Franken, I. H. A., Rassin, E., & Muris, P. (2007). The assessment of anhedonia in clinical and non-clinical populations: Further validation of the Snaith–Hamilton Pleasure Scale. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2006.08.020.

Kwaśny, A., Kwaśna, J., Wilkowska, A., Szarmach, J., Słupski, J., Włodarczyk, A., & Cubała, W. J. (2024). Ketamine treatment for anhedonia in unipolar and bipolar depression: A systematic review. European Neuropsychopharmacology, 86, 20–34. https://doi.org/10.1016/j.euroneuro.2024.04.014.

Mittmann, et al. (2025). The Snaith–Hamilton Pleasure Scale (SHAPS) and Dimensional Anhedonia Rating Scale (DARS) diverge in measuring anhedonia in a community sample of young adults. Psychiatry Research. PubMed 40997510.

National Institute for Health and Care Excellence. (2019; updated). Depression in children and young people: Identification and management (NG134). Guideline recommendations.

National Institute for Health and Care Excellence. (2022; updated). Depression in adults: Treatment and management (NG222). Guideline recommendations.

National Institute of Mental Health. (n.d.). Depression. U.S. National Institutes of Health. Official clinical information.

Ostinelli, E. G., et al. (2025). Pro-dopaminergic pharmacological interventions for anhedonia in depression: A living systematic review and network meta-analysis of human and animal studies. EBioMedicine, 121, 105967. https://doi.org/10.1016/j.ebiom.2025.105967. See also the journal's 2026 corrigendum concerning omitted contributor names.

Pugh, D., Saunders, R., Jones, A., Dunn, B. D., & Buckman, J. E. J. (2026). Evaluating the efficacy of psychotherapeutic and pharmacological treatments for depression on anhedonia: A systematic review and meta-analysis. Journal of Affective Disorders, 393, 120165. https://doi.org/10.1016/j.jad.2025.120165.

Rizvi, S. J., Quilty, L. C., Sproule, B. A., Cyriac, A., Bagby, R. M., & Kennedy, S. H. (2015). Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in a community sample and individuals with major depression. Psychiatry Research, 229(1–2), 109–119. https://doi.org/10.1016/j.psychres.2015.07.062.

Treadway, M. T., & Zald, D. H. (2011). Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neuroscience & Biobehavioral Reviews, 35(3), 537–555. https://doi.org/10.1016/j.neubiorev.2010.06.006.

Uphoff, E., et al. (2020). Behavioural activation therapy for depression in adults. Cochrane Database of Systematic Reviews, 7, CD013305. https://doi.org/10.1002/14651858.CD013305.pub2.

U.S. Department of Veterans Affairs and Department of Defense. (2022). VA/DoD clinical practice guideline for the management of major depressive disorder. Official guideline.

Wu, C., Mu, Q., Gao, W., & Lu, S. (2025). The characteristics of anhedonia in depression: A review from a clinically oriented perspective. Translational Psychiatry, 15, Article 90. https://doi.org/10.1038/s41398-025-03310-w.